Lung Cancer Clinical Trial

The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance

Summary

This research study is designed to develop and test a new supportive care program to help individuals with lung cancer improve their quality of life after cancer treatment is over.

View Full Description

Full Description

The aims of this pilot study are to evaluate the feasibility and acceptability of a brief psychoeducational intervention for participants with cancer who are transitioning from active treatment to surveillance.

The research study procedures include screening for eligibility.

This study consists of 2 parts. It is expected that about 45 people will take part in this research study.

In the first part of this study, about 5 participants will complete survey questions and receive a 5-session program.
In the second part of this study, about 40 participants will complete 3 surveys, and then will be randomly assigned to receive the 5-session program or to receive one study session (control).
These sessions will focus on providing targeted support related to life after cancer treatment. The sessions will focus on skills for coping with uncertainty, managing symptoms, improving social support, and other topics important to the individual.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age 21 or older
Diagnosis of non-small cell (NSCLC) or small cell (SCLC) lung cancer or mesothelioma
Documented treatment plan with curative intent
Ability to read and respond in English
Treatment completion eligibility:

Run-in: Has completed treatment including systemic treatments and radiation as determined within the past three weeks by the cancer care team at Massachusetts General Hospital.

RCT: Has completed treatment including systemic treatments +/- radiation and +/- surgery.

If final treatment is systemic therapy +/- radiation: within three weeks after cancer care team determination that treatment is complete.
If final treatment is surgery: within three weeks after hospital discharge following surgery.

Exclusion Criteria:

Comorbid health condition that would interfere with study participation
Current participation in cognitive behavioral therapy treatment

Study is for people with:

Lung Cancer

Estimated Enrollment:

21

Study ID:

NCT04450043

Recruitment Status:

Active, not recruiting

Sponsor:

Massachusetts General Hospital

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Massachusetts General Hospital
Boston Massachusetts, 02115, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

21

Study ID:

NCT04450043

Recruitment Status:

Active, not recruiting

Sponsor:


Massachusetts General Hospital

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider